SCHEMBL7674538

SCHEMBL7674538

O=C(NCc1ccccc1)c1c[c]cc(Nc2ccccc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 1/20 0.51
HDAC6 Q9UBN7 3/20 0.50
HDAC2 Q92769 2/20 0.50
HDAC8 Q9BY41 2/20 0.50
PPARG P37231 3/20 0.48
HPGD P15428 3/20 0.48
LMNA P02545 2/20 0.47
MAPK1 P28482 2/20 0.47
RAB9A P51151 2/20 0.47
ALDH1A1 P00352 2/20 0.46
NPC1 O15118 1/20 0.46
MITF O75030 1/20 0.46
KMT2A Q03164 1/20 0.46
EGFR P00533 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
APOBEC3A P31941 1/20 0.46
CTDSP1 Q9GZU7 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
HPGDS O60760 1/20 0.46
HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7597518 0.89 TP53 (0.50) SIRT2HDAC6HDAC2HDAC8HPGD
SCHEMBL5944048 0.85 NAMPT (0.53) HDAC6HDAC2HDAC8PPARGHPGD
SCHEMBL7592814 0.84 HDAC6 (0.43) HDAC6HDAC2HDAC8HPGDLMNA
SCHEMBL7195286 0.81 KMT2A (0.52) HPGDLMNAMAPK1ALDH1A1KMT2A
SCHEMBL7979674 0.80 EPHX2 (0.56) PPARG
SCHEMBL7114941 0.80 HDAC6 (0.53) HDAC6HDAC2HDAC8HPGDLMNA
SCHEMBL5847828 0.80 HDAC6 (0.53) HDAC6HDAC2HDAC8HPGDLMNA
SCHEMBL6195198 0.80 HDAC6 (0.56) SIRT2HDAC6HDAC2HDAC8HPGD
SCHEMBL5944155 0.80 LMNA (0.55) HDAC6HDAC2HDAC8PPARGHPGD
SCHEMBL7182884 0.78 NPC1 (0.48) LMNARAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020025947-A1 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION 2002-02-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020025947-A1 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade TFPI, TFPI2, PLAT SIRT2 2563/4885HDAC6 2841/4885HDAC2 1313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.